JHS Svendgaard Laboratories Limited has informed the Exchange about Copy of Newspaper Publication of Financial Results for the year ended 31st March, 2026
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JHS Svendgaard Laboratories has published its audited financial results for Q4 and FY26 (standalone and consolidated). Total income from operations for FY26 stood at Rs 10,169.47 lakhs, compared to Rs 9,199.73 lakhs in FY25, showing a year-on-year improvement. However, the company continues to report losses with standalone net loss after tax of Rs 192.24 lakhs for FY26 (vs loss of Rs 1,974.43 lakhs in FY25). Consolidated net loss after tax for FY26 was Rs 228.54 lakhs, significantly improved from Rs 1,250.17 lakhs in FY25. Basic EPS for standalone was negative Rs 0.22 for FY26 compared to negative Rs 2.37 in the previous year. Reserves excluding revaluation reserves stood at negative Rs 26,759.30 lakhs, indicating accumulated losses.
While losses persist, the substantial improvement from FY25 to FY26 suggests operational recovery is underway. The stock may see positive sentiment if the downward trend in losses continues, though negative reserves remain a concern for long-term shareholder value.